Mapleville, RI, United States of America

Jeanne B Lawrence

This inventor holds 12 USPTO granted patents and 1 published patent application. Top assignees: University of Massachusetts, St. Jude Children's Research Hospital. Active years: 1989-2018.

USPTO Granted Patents = 12 

% Patents Active = 83.3

Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 232(Granted Patents)


Company Filing History:


Years Active: 1989-2018

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Biography of Inventor Jeanne B Lawrence

Introduction

Jeanne B Lawrence is a prominent inventor based in Mapleville, Rhode Island, known for her significant contributions to genetic research and biotechnology. She holds a total of 12 patents, showcasing her innovative work in the field.

Latest Patents

Her latest patents include groundbreaking inventions such as "Dosage compensating transgenes and cells," which involve methods and compositions for reducing the expression of genes on Chromosome 21 by targeting an XIST transgene to specific genes. Another notable patent is "Nucleic acid silencing sequences," which features compositions and methods for introducing nucleic acids into cells to achieve chromosomal silencing, thereby reducing the expression of harmful genes.

Career Highlights

Throughout her career, Jeanne has worked with esteemed institutions, including the University of Massachusetts and St. Jude Children's Research Hospital. Her research has had a profound impact on understanding genetic disorders and developing potential therapies.

Collaborations

Jeanne has collaborated with notable colleagues such as Lisa L Hall and Robert H Singer, contributing to various research projects and advancing the field of genetics.

Conclusion

Jeanne B Lawrence's innovative work and dedication to genetic research have established her as a leading figure in her field. Her patents reflect her commitment to improving human health through scientific advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…